PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma

Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive...

Full description

Bibliographic Details
Main Authors: Cristian D. Gutierrez Reyes, Yifan Huang, Mojgan Atashi, Jie Zhang, Jianhui Zhu, Suyu Liu, Neehar D. Parikh, Amit G. Singal, Jianliang Dai, David M. Lubman, Yehia Mechref
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Metabolites
Subjects:
PRM
Online Access:https://www.mdpi.com/2218-1989/11/8/563
id doaj-1a88444d53054e619fedfa1abb02bb33
record_format Article
spelling doaj-1a88444d53054e619fedfa1abb02bb332021-08-26T14:03:58ZengMDPI AGMetabolites2218-19892021-08-011156356310.3390/metabo11080563PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular CarcinomaCristian D. Gutierrez Reyes0Yifan Huang1Mojgan Atashi2Jie Zhang3Jianhui Zhu4Suyu Liu5Neehar D. Parikh6Amit G. Singal7Jianliang Dai8David M. Lubman9Yehia Mechref10Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USADepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USADepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USADepartment of Surgery, The University of Michigan, Ann Arbor, MI 48109, USADepartment of Surgery, The University of Michigan, Ann Arbor, MI 48109, USADepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADivision of Gastroenterology and Hepatology, The University of Michigan, Ann Arbor, MI 48109, USADivision of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390, USADepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Surgery, The University of Michigan, Ann Arbor, MI 48109, USADepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USACurrently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography—parallel reaction monitoring—mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric <i>N</i>-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four <i>N</i>-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (<i>p</i> < 0.05). Strategic combinations of the significant <i>N</i>-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated <i>N</i>-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric <i>N</i>-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC<sub>AFP</sub> = 0.81, and AUC<sub>Asn207</sub> + 5-6-0-1 = 0.88, respectively).https://www.mdpi.com/2218-1989/11/8/563PRM<i>N</i>-glycopeptideshaptoglobincirrhosishepatocellular carcinoma (HCC)
collection DOAJ
language English
format Article
sources DOAJ
author Cristian D. Gutierrez Reyes
Yifan Huang
Mojgan Atashi
Jie Zhang
Jianhui Zhu
Suyu Liu
Neehar D. Parikh
Amit G. Singal
Jianliang Dai
David M. Lubman
Yehia Mechref
spellingShingle Cristian D. Gutierrez Reyes
Yifan Huang
Mojgan Atashi
Jie Zhang
Jianhui Zhu
Suyu Liu
Neehar D. Parikh
Amit G. Singal
Jianliang Dai
David M. Lubman
Yehia Mechref
PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
Metabolites
PRM
<i>N</i>-glycopeptides
haptoglobin
cirrhosis
hepatocellular carcinoma (HCC)
author_facet Cristian D. Gutierrez Reyes
Yifan Huang
Mojgan Atashi
Jie Zhang
Jianhui Zhu
Suyu Liu
Neehar D. Parikh
Amit G. Singal
Jianliang Dai
David M. Lubman
Yehia Mechref
author_sort Cristian D. Gutierrez Reyes
title PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
title_short PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
title_full PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
title_fullStr PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
title_full_unstemmed PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
title_sort prm-ms quantitative analysis of isomeric <i>n</i>-glycopeptides derived from human serum haptoglobin of patients with cirrhosis and hepatocellular carcinoma
publisher MDPI AG
series Metabolites
issn 2218-1989
publishDate 2021-08-01
description Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography—parallel reaction monitoring—mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric <i>N</i>-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four <i>N</i>-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (<i>p</i> < 0.05). Strategic combinations of the significant <i>N</i>-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated <i>N</i>-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric <i>N</i>-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUC<sub>AFP</sub> = 0.81, and AUC<sub>Asn207</sub> + 5-6-0-1 = 0.88, respectively).
topic PRM
<i>N</i>-glycopeptides
haptoglobin
cirrhosis
hepatocellular carcinoma (HCC)
url https://www.mdpi.com/2218-1989/11/8/563
work_keys_str_mv AT cristiandgutierrezreyes prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT yifanhuang prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT mojganatashi prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT jiezhang prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT jianhuizhu prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT suyuliu prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT neehardparikh prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT amitgsingal prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT jianliangdai prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT davidmlubman prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
AT yehiamechref prmmsquantitativeanalysisofisomericiniglycopeptidesderivedfromhumanserumhaptoglobinofpatientswithcirrhosisandhepatocellularcarcinoma
_version_ 1721191546509852672